CAS: 233275-76-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | MK 0343 REF: IN-DA00BFC6CAS: 233275-76-8 | 99% | To inquire | Mon 03 Mar 25 |
 | MK 0343 REF: 10-F500537CAS: 233275-76-8 | 95.0% | To inquire | Thu 13 Mar 25 |
 | MK 0343 REF: 3D-IJA27576CAS: 233275-76-8 | Min. 95% | To inquire | Mon 14 Apr 25 |
 | MK-0343 REF: TM-T16084CAS: 233275-76-8 | 98% | 187.00 €~2,072.00 € | Mon 21 Apr 25 |
Ref: IN-DA00BFC6
| 5mg | 295.00 € | ||
| 10mg | 497.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 3 Mar 2025
MK 0343
CAS:233275-76-8
MK 0343 is a drug that has been in clinical development for the treatment of …
Formula:
C19H17F2N7O
Purity:
Min. 95%
Molecular weight:
397.38 g/mol
Ref: 3D-IJA27576
| 25mg | 1,298.00 € | ||
| 50mg | 1,805.00 € |
Estimated delivery in United States, on Monday 14 Apr 2025
MK-0343
CAS:233275-76-8
MK0343 is an orally bioavailable GABAA receptor subtype-selective partial agonist and is a non-sedating anxiolytic.
Formula:
C19H17F2N7O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
397.38
Ref: TM-T16084
| 2mg | 187.00 € | ||
| 25mg | 1,045.00 € | ||
| 50mg | 1,369.00 € | ||
| 100mg | 2,072.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
